Icon, Probuild, CPB, Watpac Likely to Tender for $1.8B Vaccine Plant in Melbourne’s North-West
Melbourne’s Tullamarine is set to become home to a $1.8 billion high-tech vaccine plant which will promise a supply of medical products until 2036.
The building of the new plant in Melbourne Airport Business Park will create over 520 new construction jobs.
The Federal Government has agreed to sign a $1 billion contract with immunology developer Seqirus in order to secure the plant.
Seqirus has agreed to invest $800m into the new facility which aims to have it ready for operation by 2026.
The vaccine manufacturing plant will provide an ongoing supply of vaccines and antivenoms throughout Australia to combat the spread of viruses not dissimilar to COVID-19.
The new vaccine plant will be the largest in the southern hemisphere and will respond to critical health conditions that can be treated by vaccination throughout the country.
Australia’s acquisition of the new plant was planned prior to the global outbreak of COVID-19, with Prime Minister Scott Morrison having visited the site in February of this year.
“Keeping Australians safe is my number one priority and while we are rightly focused on both the health and economic challenges of COVID-19, we must also guard against future threats,” the Prime Minister said.
Probuild, Icon, CPB, and Watpac are expected to tender for this project.
Probuild’s past government contracts have included the Melbourne Convention and Exhibition Centre, valued at $300m, and The Shrine of Remembrance Galleries.
Probuild is currently building the first stage of the global biotech company, CSL Limited’s headquarters. This project is valued at $750m in mixed-use development and sees Probuild working on a 70,000 sq m site.
Icon’s record of government work includes building the Parliament House Accommodation Project, working on the Junction Oval redevelopments, and The Department of Primary Industry’s Attwood campus, valued at $20m.
In 2017, Icon built the AlbuRx and Strategic Capacity Expansion Project for CSL valued at $34m. This project was designed as a pharmaceutical manufacturing plant in Broadmeadows.
CPB’s portfolio of notable work includes the $11b Metro Tunnel Project, upgrades to Melbourne Airport and the Melbourne Water Treatment Plant Upgrade.
Watpac have completed major projects including; Casey Hospital Expansion valued at $135m and Single LEAP Phase 1 and Phase 2 for the Department of Defence, valued at $469m.
Watpac’s current work in the pharmaceutical space includes Asterion’s $400m medicinal cannabis facility in Toowoomba, Queensland.
You’ll need a Conecta Member profile to receive the latest construction news and industry leading content in 2021. It’s free and takes minutes. Sign up now.
Image source: The Australian
Richmond VIC, 3121Apply Now
Download the 2021 Construction Industry Trends, Predictions & Salary Guide Now
Over 15,000 construction professionals stay connected to industry with Conecta